Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWAmorolfine is an antifungal.1 It is active against isolates of T. rubrum, T. mentagrophytes, and C. albicans (MIC90s = 4-15, 4-60, and ≤30-500 ng/ml, respectively). It inhibits the growth of T. mentagrophytes and T. rubrum by 33.7 and 38.5%, respectively, in an in vitro bovine hoof model of onychomycosis.2 Amorolfine also decreases the fungal burden in a rabbit model of onychomycosis when used as a 5% nail lacquer.3 Formulations containing amorolfine have been used in the treatment of fungal infections of the toe- or fingernails.
WARNING This product is not for human or veterinary use.
1. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis. Antimicrob. Agents Chemother. 57(4), 1610-1616 (2013).
2. Development of a novel in vitro onychomycosis model for the evaluation of topical antifungal activity. J. Microbiol. Methods 112, 73-75 (2015).
3. Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents. Antimicrob. Agents Chemother. 55(7), 3150-3155 (2011).